← FDA Drug Approvals (Drugs@FDA)
MIRABEGRON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2022-09-28
Drug application
- FDA Application #
ANDA209485- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIRABEGRON
- Generic name
- MIRABEGRON
- Active ingredients
- MIRABEGRON
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LUPIN
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2022-09-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown